101 related articles for article (PubMed ID: 34312652)
1. Consumption of quinolones in the community, European Union/European Economic Area, 1997-2017.
Adriaenssens N; Bruyndonckx R; Versporten A; Hens N; Monnet DL; Molenberghs G; Goossens H; Weist K; Coenen S;
J Antimicrob Chemother; 2021 Jul; 76(12 Suppl 2):ii37-ii44. PubMed ID: 34312652
[TBL] [Abstract][Full Text] [Related]
2. Consumption of penicillins in the community, European Union/European Economic Area, 1997-2017.
Bruyndonckx R; Adriaenssens N; Hens N; Versporten A; Monnet DL; Molenberghs G; Goossens H; Weist K; Coenen S;
J Antimicrob Chemother; 2021 Jul; 76(12 Suppl 2):ii14-ii21. PubMed ID: 34312657
[TBL] [Abstract][Full Text] [Related]
3. Change-points in antibiotic consumption in the community, European Union/European Economic Area, 1997-2017.
Bruyndonckx R; Hoxha A; Quinten C; Ayele GM; Coenen S; Versporten A; Adriaenssens N; Muller A; Heuer O; Monnet DL; Goossens H; Molenberghs G; Weist K; Hens N;
J Antimicrob Chemother; 2021 Jul; 76(12 Suppl 2):ii68-ii78. PubMed ID: 34312659
[TBL] [Abstract][Full Text] [Related]
4. Consumption of antibiotics in the community, European Union/European Economic Area, 1997-2017: data collection, management and analysis.
Bruyndonckx R; Adriaenssens N; Versporten A; Hens N; Monnet DL; Molenberghs G; Goossens H; Weist K; Coenen S;
J Antimicrob Chemother; 2021 Jul; 76(12 Suppl 2):ii2-ii6. PubMed ID: 34312651
[TBL] [Abstract][Full Text] [Related]
5. Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014-2018: Findings and Implications from ESAC-Net and WHO Europe.
Robertson J; Vlahović-Palčevski V; Iwamoto K; Högberg LD; Godman B; Monnet DL; Garner S; Weist K; ;
Front Pharmacol; 2021; 12():639207. PubMed ID: 34220495
[No Abstract] [Full Text] [Related]
6. Analysing the trend over time of antibiotic consumption in the community: a tutorial on the detection of common change-points.
Bruyndonckx R; Coenen S; Adriaenssens N; Versporten A; Monnet DL; Goossens H; Molenberghs G; Weist K; Hens N;
J Antimicrob Chemother; 2021 Jul; 76(12 Suppl 2):ii79-ii85. PubMed ID: 34312655
[TBL] [Abstract][Full Text] [Related]
7. Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU/EEA, 2022.
Ventura-Gabarró C; Leung VH; Vlahović-Palčevski V; Machowska A; Monnet DL; Högberg LD; ;
Euro Surveill; 2023 Nov; 28(46):. PubMed ID: 37971660
[TBL] [Abstract][Full Text] [Related]
8. Consumption of antibiotics in the community, European Union/European Economic Area, 1997-2017.
Bruyndonckx R; Adriaenssens N; Versporten A; Hens N; Monnet DL; Molenberghs G; Goossens H; Weist K; Coenen S;
J Antimicrob Chemother; 2021 Jul; 76(12 Suppl 2):ii7-ii13. PubMed ID: 34312654
[TBL] [Abstract][Full Text] [Related]
9. Effect of antibiotic stewardship interventions in primary care on antimicrobial resistance of Escherichia coli bacteraemia in England (2013-18): a quasi-experimental, ecological, data linkage study.
Aliabadi S; Anyanwu P; Beech E; Jauneikaite E; Wilson P; Hope R; Majeed A; Muller-Pebody B; Costelloe C
Lancet Infect Dis; 2021 Dec; 21(12):1689-1700. PubMed ID: 34363774
[TBL] [Abstract][Full Text] [Related]
10. Regional variation in the potentially inappropriate first-line use of fluoroquinolones in Canada as a key to antibiotic stewardship? A drug utilization review study.
St-Jean A; Chateau D; Dahl M; Ernst P; Daneman N; Sketris IS; Zhang J; Marra F; Quail J; Bugden S;
BMC Infect Dis; 2021 Aug; 21(1):733. PubMed ID: 34344348
[TBL] [Abstract][Full Text] [Related]
11. Impact of Daridorexant, a Dual Orexin Receptor Antagonist, on Cardiac Repolarization Following Bedtime Dosing: Results from a Thorough QT Study Using Concentration-QT Analysis.
Schilling U; Henrich A; Muehlan C; Krause A; Dingemanse J; Ufer M
Clin Drug Investig; 2021 Aug; 41(8):711-721. PubMed ID: 34331678
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous photocatalysis of moxifloxacin at a pilot solar compound parabolic collector: Elimination of the genotoxicity.
Maffessoni D; Grazziotin IC; Klauck CR; Benvenuti T; da Silva SW; Meneguzzi A
J Environ Manage; 2021 Nov; 297():113296. PubMed ID: 34329908
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of antimicrobial resistance selection in Neisseria gonorrhoeae.
Allen GP; Deao KM; Hill SA; Schipelliti SM; Tran T
Int J Antimicrob Agents; 2021 Oct; 58(4):106417. PubMed ID: 34391903
[TBL] [Abstract][Full Text] [Related]
14. Long-term residual cardiovascular risk after acute coronary syndrome: antithrombotic treatment options.
Chan Pin Yin DRPP; Ten Berg JM
Neth Heart J; 2022 Jan; 30(1):38-46. PubMed ID: 34357557
[TBL] [Abstract][Full Text] [Related]
15. Twenty-four-week interim outcomes of bedaquiline-containing regimens in treatment of adolescents with rifampicin-resistant tuberculosis: A retrospective cohort study in China.
Wu HY; Tian Y; Wang XD; Sun JS; Fan LC; Chen MX; Li R; Chen Y
J Paediatr Child Health; 2022 Jan; 58(1):116-121. PubMed ID: 34323328
[TBL] [Abstract][Full Text] [Related]
16. Interactions between staphylococcal enterotoxins A and D and superantigen-like proteins 1 and 5 for predicting methicillin and multidrug resistance profiles among Staphylococcus aureus ocular isolates.
Lu M; Parel JM; Miller D
PLoS One; 2021; 16(7):e0254519. PubMed ID: 34320020
[TBL] [Abstract][Full Text] [Related]
17. Identification of drugs associated with reduced severity of COVID-19 - a case-control study in a large population.
Israel A; Schäffer AA; Cicurel A; Cheng K; Sinha S; Schiff E; Feldhamer I; Tal A; Lavie G; Ruppin E
Elife; 2021 Jul; 10():. PubMed ID: 34313216
[TBL] [Abstract][Full Text] [Related]
18. Consumption of cephalosporins in the community, European Union/European Economic Area, 1997-2017.
Versporten A; Bruyndonckx R; Adriaenssens N; Hens N; Monnet DL; Molenberghs G; Goossens H; Weist K; Coenen S;
J Antimicrob Chemother; 2021 Jul; 76(12 Suppl 2):ii22-ii29. PubMed ID: 34312658
[TBL] [Abstract][Full Text] [Related]
19. Small scale in vitro method to determine a bioequivalent equilibrium solubility range for fasted human intestinal fluid.
Abuhassan Q; Khadra I; Pyper K; Halbert GW
Eur J Pharm Biopharm; 2021 Nov; 168():90-96. PubMed ID: 34419602
[TBL] [Abstract][Full Text] [Related]
20. Moxifloxacin-induced oral erythema multiforme: An unusual adverse effect hitherto unreported.
Das S; Rudra O; Sharma S; Mallick S
Indian J Pharmacol; 2021; 53(4):298-300. PubMed ID: 34414908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
